Podcasts about clinician scientist

TIIM Healthcare is transforming emergency care with AI-powered solutions that support faster, more accurate triage decisions. Their flagship product, aiTriage, leverages heart rate variability and artificial intelligence to detect high-risk patients early. With support from the National Health Innovation Centre (NHIC), TIIM Healthcare has successfully launched clinical trials and built vital partnerships with hospitals like SGH and NUH, accelerating adoption and driving real-world impact in healthcare delivery. On The Right Business, Hongbin Jeong speaks to Prof Marcus Ong, Senior Consultant and Clinician Scientist at the Department of Emergency Medicine, Singapore General Hospital, and Dr Pauline Erica Tay, Director at the National Health Innovation Centre, Singapore, to find out more. Presented by: Hongbin Jeong Produced and Edited by: Alexandra Parada (alexparada@sph.com.sg) and Nadiah Koh Want to get featured on our show? Drop me an email today!See omnystudio.com/listener for privacy information.

In this inaugural episode of DocTalks, we introduce a brand-new branch of Podagogies dedicated to exploring the world of medical education. Co-hosts Curtis Maloley and Chelsea Jones welcome the new DocTalks co-host, Dr. Heather McNeil, Interim Assistant Dean of Faculty Development at the TMU School of Medicine. To kick things off, we're joined by Dr. Teresa Chan, an educational leader, researcher, and the founding Dean of the School of Medicine. Together, we dive into the evolving role of medical educators, the importance of mentorship, and how technology—from podcasts to AI tutors—is transforming how future healthcare professionals are trained. Dr. Teresa M. Chan is the Founding Dean of the Toronto Metropolitan University School of Medicine as well as TMU's Vice-President, Medical Affairs. Previously, she served as Associate Dean, Continuing Professional Development and an Associate Professor, Division of Emergency Medicine, Department of Medicine in the Faculty of Health Sciences at McMaster University. She was also a Clinician Scientist with McMaster Education, Research, Innovation and Theory (MERIT), and has been a practicing emergency physician with Hamilton Health Sciences since 2013. Follow DocTalks on Soundcloud: https://soundcloud.com/doctalks-presented-by-podagogies/doctalks-episode-1 Read the transcript: https://tinyurl.com/8tr26wey

Welcome back Rounds Table Listeners!We are back this week with a special podcast episode! Dr. Mike Fralick sits down with Dr. Amy Yu, a Stroke Neurologist, Clinician-Scientist, and Associate Professor of Medicine at the University of Toronto and Sunnybrook Hospital, to chat about her hot-off-the press publication - Population-Level Screening for Diabetes and Dyslipidemia After Pregnancies Complicated by Hypertension or Diabetes!Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

In this episode of The Cancer Researcher Podcast, we welcome back Professor Carlos Caldas, Clinician Scientist and Professor of Cancer Medicine at the University of Cambridge. As a keynote speaker and member of the Scientific Program Committee for the upcoming EACR Congress, he shares insights into his breast cancer research, the evolution of cancer science, and the power of patient-derived xenograft models. We also discuss the Congress programme, networking tips for early-career researchers, and why Lisbon is the perfect host city.

In this episode of Onc Now, Jonathan is joined by Dr Dave Cescon, a Medical Oncologist and Clinician Scientist at the Princess Margaret Cancer Centre, Toronto, Canada. Together, they explore the transformative impact of CDK4/6 inhibitors, challenges in liquid biopsy research, and the potential of mRNA vaccines in oncology.  Timestamps: (02:44) -Swimming in Toronto: Competitive vs. Open Water  (08:06) -From Internal Medicine to Breast Cancer Research  (14:09) -Translational research and circulating tumour DNA  (19:53) -The role of CDK4/6 inhibitors in breast cancer  (29:04) -FDA approval of ribociclib for high-risk early breast cancer  (31:45) -The future of mRNA vaccines for personalised cancer care  (37:34) -Dave's research challenges and innovations  (39:13) -Three wishes for healthcare 

Clinician Scientist-Programme geben jungen ÄrztInnen die Möglichkeit, während der Facharztausbildung wissenschaftlich zu arbeiten und auf international wettbewerbsfähigem Niveau zu forschen. Denn im normalen klinischen Alltag bleibt kaum Zeit für ehrgeizige Forschungsprojekte, die meist in den Feierabend verlegt werden (müssen). Das erklärt, warum es bundesweit an klinischen ForscherInnen fehlt. Dr. Veronika Bahlinger ist Assistenzärztin am Institut für Pathologie des Universitätsklinikum Tübingen und absolviert zurzeit das Clinician Scientist-Programm. Perfekte Kandidatin also, um einmal das Programm näher zu beleuchten. Es war spannend! Wir wünschen viel Freude beim Zuhören!   Patho aufs Ohr geht nun in die Semesterferien. Wir hören uns wieder am 07.04.2025!   Wenn ihr uns etwas mitteilen wollt, schreibt uns gerne! sven.perner@pathopodcast.de linkedin.com/in/prof-dr-med-sven-perner-6a771b48   christiane.kuempers@pathopodcast.de linkedin.com/in/pd-dr-med-christiane-charlotte-kümpers-279a382

The Right Reverend Rose Hudson-Wilkin, the Bishop of Dover, is a trailblazer, who has been right at the heart of a changing nation for over 40 years. Despite discrimination due to her gender and ethnic minority background, Bishop Rose has never wavered from the call she received to enter ministry at the age of 14. She joined Nuala McGovern to discuss her memoir, The Girl from Montego Bay.A Royal College of Nursing report, On the Frontline of the UK's Corridor Care Crisis, which came out this week, found that the situation in A&E is the worst it has ever been and that a lack of hospital beds means corridor care has been "normalised". One nurse described caring for a 95-year-old woman dying with dementia who had spent eight hours lying on a trolley in a crowded corridor next to a drunk person who was vomiting and being abusive. Others describe women having a miscarriage in side rooms. Professor Nicola Ranger, Chief Executive of the Royal College of Nursing joined Anita Rani to discuss what is going on.Holly Bourne, bestselling author of How Do You Like Me Now? and the Spinster Club series, is back with So Thrilled For You, her most personal novel yet. It's a story about four friends navigating motherhood, career ambition, and societal pressures, all unfolding during a sweltering summer's day at a baby shower. Holly joined Nuala and explained what inspired this book. Can AI improve the success rates of women undergoing fertility treatment? Anita discusses the impact of AI on IVF with Dr Cristina Hickman, an embryologist, co-founder of Avenues, and Chair of the Global AI Fertility Society, and Dr Ali Abbara, a Clinician Scientist at Imperial College London, and Consultant in Reproductive Endocrinology at Imperial College Healthcare NHS Trust.Hermine Braunsteiner was the first person to be extradited from the US for Nazi war crimes. She was one of a few thousand women who had worked as a concentration camp guard and was nicknamed ‘the Mare' by prisoners because of her cruelty; she kicked people to death. In 1964, Hermine's past was unknown: She was living a quiet existence as an adoring suburban housewife in Queens, New York when she was tracked down by a reporter from The New York Times who exposed her past. Angharad Hampshire, a Research Fellow at York St John University, joined Nuala to talk about The Mare, her novel based on Hermine's life.The all-female, Welsh-language, post-punk trio Adwaith are the only band to have won the Welsh Music Prize twice, for their first two albums. They are about to release their third album, Solas, all about returning to their hometown in Carmarthen. Band members Hollie Singer, Gwenedd Owen and Gwen Anthony performed live in the studio. Presenter: Anita Rani Producer: Annette Wells Editor: Rebecca Myatt

Can AI improve the success rates of women undergoing fertility treatment? Anita Rani discusses the impact of AI on IVF with Dr Cristina Hickman, an embryologist, co-founder of Avenues, and Chair of the Global AI Fertility Society, and Dr Ali Abbara, a Clinician Scientist at Imperial College London, and Consultant in Reproductive Endocrinology at Imperial College Healthcare NHS Trust.The second reading is due today of a private members bill that seeks to ban first-cousin marriage. It's particularly prevalent among Pakistani and Muslim communities. But what would this mean for women? And how would genetic testing to enforce the ban work? Anita Rani speaks to CEO of Karma Nirvana Natasha Rattu and Emeritus Professor of Health Research at Bradford University, Neil Small. The award winning documentary Sugarcane follows an investigation into the Canadian Indian residential school system, and the attempts of survivors and their descendants to try to understand what happened in them. Emily Kassie is the film's producer and co-director and joins Anita on Woman's Hour. Mark Zuckerberg says companies need to embrace more “masculine energy”. The Meta boss told a podcast that instead of trying to get away from it, corporate culture should celebrate the positive side of things like “aggression”. But what even is ‘masculine energy'? And do we really need more of it? Anita talks to Josh Smith, contributing editor of Glamour magazine and Becky Hewitt, Chief Exec of culture change company Kin&Co.Presenter: Anita Rani Producer: Laura Northedge

Seg 1: Inside the mind-bending Alice and Wonderland Syndrome Guest: Dr. Maximilian Friedrich, Clinician-Scientist in Neurology at the Center for Brain Circuit Therapeutics at Brigham and Women's Hospital and Research Fellow at Harvard Medical School  Seg 2: Scott's Thoughts: The most overrated movies in history Guest: Scott Shantz, CKNW Contributor Seg 3: View From Victoria: Neck and Neck going into the election We get a local look at the top political stories with the help of Vancouver Sun columnist Vaughn Palmer. Seg 4: How Diddy's arrest sheds light on sex trafficking in North America Guest: Dr. Kimberly Mehlman-Orozco, Human Trafficking Expert Witness and Author of “Hidden in Plain Sight: America's Slaves of the New Millennium” Seg 5: Can age restrictions actually stop kids from viewing explicit websites? Guest: Elaine Craig, Professor of Law at Dalhousie University and Author of “Mainstreaming Porn: Sexual Integrity and the Law Online” Seg 6: Are KPU students really trying to shut down their school paper? Guest: Claudia Culley, Editor and Chief of Kwantlen Polytechnic University's Student Newspaper “The Runner” Seg 7: Will Instagram's new restrictions be enough to keep teens safe? Guest: Niki Sharma, Attorney General of British Columbia Seg 8: Have local paleontologists discovered an entirely new dinosaur species? Guest: Derek Larson, Collections Manager and Researcher in Palaeontology at the Royal BC Museum Learn more about your ad choices. Visit megaphone.fm/adchoices

Inside the mind-bending Alice and Wonderland Syndrome Guest: Dr. Maximilian Friedrich, Clinician-Scientist in Neurology at the Center for Brain Circuit Therapeutics at Brigham and Women's Hospital and Research Fellow at Harvard Medical School Learn more about your ad choices. Visit megaphone.fm/adchoices

MEDICAL RECORD: WHAT A NEW STUDY TELLS US ABOUT THE USE OF AI IN TREATING HOSPITAL PATIENTS Libby Znaimer is joined by Dr. Alisa Naiman, a family doctor in Toronto, Dr. Amol Verma, Clinician-Scientist at St. Michael's Hospital and Temerty Professor of AI Research and Education in Medicine at the University of Toronto, and Dr. Aaron Schimmer, the Director of Research at the Princess Margaret Cancer Centre as well as a staff physician and a senior scientist. Today we discuss a groundbreaking study co-authored by Dr. Amol Verma on the use of AI and how it has contributed to a 26 percent reduction in unexpected deaths for patients being treated in hospital. And, should we be moving away from the Body Mass Index and instead use the Body Roundness Index (also known as BRI)? THE DEBATE AROUND THE FILM "RUSSIANS AT WAR" WHICH SPARKED CONTROVERSY AT THIS YEAR'S TIFF Libby Znaimer is now joined by freelance journalist Justin Ling and Chris Alexander, Canada's former ambassador to Afghanistan and Minister of Immigration under former Prime Minister Stephen Harper. "Russians at War" was going to premiere at TIFF this year but was cancelled amid public backlash and protest. The festival said they suspended the screenings of the film in response to "significant threats". But this week, the film was back on. Yesterday's screening was greeted by another demonstration by members of the Ukrainian community and supporters claiming that this was just a piece of Russian propaganda. Was this censorship or an attempt to fend off Russian propaganda from infiltrating us and influencing our elections and our people? PIERRE POILIEVRE EXPECTED TO INTRODUCE NON- CONFIDENCE MOTION NEXT WEEK Libby Znaimer is joined by Bob Richardson, a Public Affairs Consultant, and Jason Lietaer, a Conservative Strategist and President of Enterprise. Pierre Poilievre is set to introduce a non-confidence motion next week. The question is, can the Conservatives get the support they need from the Bloc Québécois and NDP? And, if they fail, what can we expect from the Conservatives in future in terms of trying to get a vote of non-confidence? Meanwhile, did you see the video of NDP leader Jagmeet Singh confronting protestors on Parliament Hill? Did he do a good job of responding to the situation?

In this podcast episode, Dr. Versha Banerji discusses the role of non-covalent BTK inhibitors for the treatment of CLL. Our Guest:Dr. Versha Banerji is a Clinician Scientist at CancerCare Manitoba and Senior Scientist at the Research Institute in Oncology and Hematology, based in Winnipeg, Manitoba.If you enjoyed our podcast episode, please review and subscribe. For other medical education content, visit our website at: https://www.impactmedicom.comThis episode was funded by Eli Lilly, Canada. 

The most commonly used equation that determines someone's kidney function includes a binary male-female sex coefficient. But what does this mean for the care of transgender, gender-diverse, and nonbinary people? Cameron Whitley, an associate professor with kidney failure experience, and researchers Keila Turino Miranda, a PhD student, and Dr. David Collister, a nephrologist, shed light on this important topic.   Dr. David Collister (he/him) is a Kidney Doctor, Clinician-Scientist and Assistant Professor at the University of Alberta. He has a PhD in Health Research Methodology from McMaster University. His research program is funded by the Canadian Institutes of Health Research and the Kidney Foundation of Canada and focuses on randomized controlled trials of interventions for uremic symptoms, cannabinoids, the responsiveness of uremic symptoms to the initiation of dialysis, metabolomics, proteomics and the intersection of gender diversity and kidney disease. Keila Turino Miranda (she/her) is a first year PhD Student in the Cardiovascular Health and Autonomic Regulation Laboratory at McGill University. Ms. Turino Miranda's work focuses on understanding and addressing the unique healthcare needs and disparities faced by transgender, gender-diverse, and non-binary (TGD) individuals in the realms of nephrology and cardiology using a patient-oriented approach. Cameron T. Whitley, Ph.D. (he/they) is an Associate Professor in the Department of Sociology at Western Washington University. He studies issues concerning the environment, human-animal relationships, and transgender-affirming medicine. He got involved with studying transgender-affirming medicine when he was diagnosed with kidney failure and received a kidney transplant while writing his dissertation. Through this process, he coauthored one of the first articles addressing the discrepancies in evaluating kidney function for transgender people. He has over five dozen publications featured in places like Proceedings of the National Academy of Sciences, Academic Emergency Medicine, Clinical Chemistry, and Annual Review of Sociology.   Additional resources: Kidney Function in a Gender Diverse Landscape   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

Dr. Andrew Loblaw (Radiation Oncologist (Sunnybrook Research Institute), Clinician Scientist, and dual Professor in the Department of Radiation Oncology and the Institute of Health Policy Management & Evaluation at the University of Toronto) takes time out of the busy 2024 Canadian Urological Association Annual Meeting schedule to chat with Dr. Aly-Khan Lalani and Dr. Christopher Wallis. Dr. Loblaw provides an overview of how he treats his patients, including shifting to hypofractionation, brachytherapy boosts and more. Keep an eye out for Episode 13, which is the second and final part of this mini-series! This podcast has been made possible through unrestricted financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Merck, Novartis, Pfizer and TerSera. The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: https://theviewongu.com

People are living longer, but the cost of caregiving is something many Canadians don't plan for. Our guest this episode is Dr. Zahinoor Ismail. He's a dementia expert and Clinician Scientist at the Hotchkiss Brain Institute at the University of Calgary. He'll tell us all about the often overlooked emotional and financial impacts of caring for those with dementia as well as the research he's doing with the help of charity Gordie Howe CARES.  For more information on the University of Calgary CAN-PROTECT caregiver study and for caregiver resources visit Gordie Howe CARES.  Key moments this episode:  1:27 – What exactly is dementia and how it is different from Alzheimer's?  3:23 – What is meant by the term “caregiver”? How has the definition evolved?  5:46 – Three major factors that can contribute to the burden on a family/friend caregiver  10:19 – The financial and emotional cost of caring for a loved one  11:20 – How Gordie Howe CARES is helping caregivers  14:20 – An example of the financial burdens of caregiving  15:14 – What about the taboo around having a loved one with cognitive decline? How does that affect caregivers?  15:56 – The two things Dr. Ismail finds rewarding about this work  17:33 – How can caregiving be made a positive experience?  

Prof. Krug ist Gastroenterologe und stellvertretender ärztlicher Direkter der Gastroenterologie an der Uniklinik Heidelberg. Auf seinem Weg hat er an mehreren Standorten als Clinician Scientist an vielen Pankreaserkrankungen gearbeitet und geforscht. In dieser Gastfolge besprechen wir die Pathophysiologie hinter der Pankreatitis und erfahren über die Arbeit als forschender Kliniker. Hört rein!

This episode features a conversation about bias in healthcare AI models with Dr Xiao Liu- Senior Clinician Scientist in AI & Digital Health, University Hospitals Birmingham NHS Foundation Trust. Discussion topics include: How does AI bias arise?  How can we tell whether AI algorithms are biased? Who should be held accountable for bias in AI systems? Is AI the solution for AI bias? Papers referenced during the discussion: Ethical Machine Learning in Healthcare: https://pubmed.ncbi.nlm.nih.gov/34396058/ Standing together recommendations: https://www.datadiversity.org/about

In the time that it takes to say this sentence – three seconds – someone in the world will develop dementia, a group of symptoms impacting memory, thinking, mood, behaviour and the ability to complete everyday tasks. Alzheimer's is the most common form of dementia.With people living longer, even into their 90s and beyond, dementia is becoming the biggest and most consequential global health threat of our time. But, according to a landmark study in The Lancet medical journal, there are 12 modifiable risk factors that can reduce your chances of getting dementia at any age – by up to 40%. In this episode of Your Complex Brain, we discuss which of those risk factors are most impactful to lower – or even reverse – your risk of dementia, with a focus on the latest science looking at the benefits of exercise.Featuring: Maria Martinez has been a social worker nearly 25 years. Most recently, she has worked with the team at UHN's Memory Clinic, helping patients living with Alzheimer's and dementia, and their families, navigate their diagnosis and community supports.Dr. Carmela Tartaglia is a Neurologist and a Clinician Scientist with UHN's Krembil Brain Institute, as well as co-Director of UHN's Memory Clinic and an Associate Professor at the University of Toronto.Dr. Laura Middleton is an associate professor and the Schlegel Research Chair in Dementia and Active Living, at the University of Waterloo. She is also an Affiliate Scientist at KITE, the research arm of UHN's Toronto Rehabilitation Institute. Additional resources: Dr. Carmela Tartaglia's interview on EP 1 of Your Complex Brain – ‘The Quest to Solve the Concussion Problem'Risk Factors for Alzheimer's and Dementia (video)UHN Memory ClinicSchlegel-UW Research Institute for Aging (RIA)Dr. Laura Middleton's research project - DREAM (Dementia Resources for Eating, Activity, and Meaningful InclusionDr. Laura Middleton's research project - DICE (Dementia Inclusive Choices for Exercise)The Your Complex Brain production team is Heather Sherman, Jessica Schmidt, Dr. Amy Ma, Kim Perry, Sara Yuan, Meagan Anderi, Liz Chapman, and Lorna Gilfedder.The Krembil Brain Institute, part of University Health Network, in Toronto, is home to one of the world's largest and most comprehensive teams of physicians and scientists uniquely working hand-in-hand to prevent and confront problems of the brain and spine, such as Parkinson's, Alzheimer's, epilepsy, stroke, spinal cord injury, chronic pain, brain cancer or concussion, in their lifetime. Through state-of-the-art patient care and advanced research, we are working relentlessly toward finding new treatments and cures.Do you want to know more about the Krembil Brain Institute at UHN? Visit us at: uhn.ca/krembilTo get in touch, email us at krembil@uhn.ca or message us on social media:Instagram - @krembilresearchTwitter - @KBI_UHNFacebook - https://www.facebook.com/KrembilBrainInstituteThanks for listening!

Welcome to the 2nd episode in our Critical Care Forum Canada 2023 podcast series, where we interview leading Canadian experts. In this episode, we explore the intersection of artificial intelligence and critical care medicine with Dr. Shelly Dev and David Maslove, recorded after a panel discussion held at the Conference in Toronto. Dr Dev is no stranger to our podcast and is a staff intensivist at Sunnybrook Health Sciences Centre, Toronto, Canada, where she serves as the director of education for Critical Care Medicine. Dr Maslove is a Clinician Scientist and Intensivist at Queen's University, Kingston, Canada. His research focuses on the use of physiologic and genomic data to advance precision medicine in the ICU.

In this episode, Daniel Arnold sits down with Dr. Kate Hanneman. Dr. Hanneman is an Associate Professor and Vice Chair of Research at the University of Toronto and a Clinician Scientist at the Toronto General Hospital Research Institute. She is Co-Chair of the Canadian Association of Radiologists Sustainability Working Group and Deputy Lead for Sustainability at the Joint Department of Medical Imaging and University Medical Imaging Toronto. She is an Associate Editor with Radiology, the Journal of Cardiovascular Magnetic Resonance, and the Canadian Association of Radiologists Journal and leads an active research program focused on improving health outcomes for patients using cardiac imaging.     Dr. Hanneman shares her journey from being a patient to becoming a radiologist, emphasizing the crucial role of mentorship in medical education. The discussion explores Dr. Hanneman's current role in the Department of Medical Imaging at the University of Toronto and her unique position within the Canadian healthcare system. Dr. Hanneman discusses her dedication to cardiac imaging research, highlighting its interdisciplinary and collaborative nature. The episode also highlights the challenges and advantages of the Canadian healthcare system. Towards the end, the conversation shifts to Kate's involvement in sustainability efforts within radiology, addressing the environmental impact of the field. The podcast concludes with insights into the intersection of AI and sustainability in radiology, offering a glimpse into Kate Hanneman's professional journey and the fascinating world of cardiac imaging.   Learn more at https://medality.com/the-radiology-report-podcast

Dr. Jia Ng - The Clinician Scientist Life Dr. Jia Ng is a nephrologist, researcher, and the founder of PublishedMD consulting. What's nephrology? What does her research involve? What's PublishedMD consulting? Lots of questions, so let's get some answers. Check out the PublishedMD YouTube channel at https://www.youtube.com/@PublishedMD. __ TEACH THE GEEK (teachthegeek.com) Subscribe and rate on Apple Podcasts, Spotify, and YouTube Follow @teachthegeek (Twitter) and @_teachthegeek_ (IG) Get Public Speaking Tips for STEM Professionals at http://teachthegeek.com/tips

Welcome back Rounds Table Listeners! In this throwback episode, Dr. Justin Boyle sits down with Dr. Jennifer Flemming, a Clinician-Scientist and Gastroenterologist at Queen's University, to chat about portal hypertension and the Baveno 7 Guidelines! Questions? Comments? Feedback? We'd love to hear from you! @roundstable The post TBT – Portal Hypertension for the Internist with Dr. Flemming first appeared on Healthy Debate. The post TBT – Portal Hypertension for the Internist with Dr. Flemming appeared first on Healthy Debate.

Welcome back Rounds Table Listeners! In this throwback episode, Dr. Justin Boyle sits down with Dr. Jennifer Flemming, a Clinician-Scientist and Gastroenterologist at Queen's University, to chat about portal hypertension and the Baveno 7 Guidelines! Questions? Comments? Feedback? We'd love to hear from you! @roundstableThe post TBT – Portal Hypertension for the Internist with Dr. Flemming appeared first on Healthy Debate.

Welcome to the Plant-Based Canada Podcast. In this episode we are joined by Dr. Kate Hanneman to chat about climate change and environmental sustainability in health care practices, particularly medical imaging/radiology, as well as improving health outcomes for patients using cardiac imaging.Kate Hanneman MD MPH, is an Associate Professor at the University of Toronto and a Clinician Scientist at the Toronto General Hospital Research Institute. She is the author of over 100 peer-reviewed papers and leads an active research program focused on sustainability and improving health outcomes for patients using cardiac imaging. She is Co-Chair of the Canadian Association of Radiologists Sustainability Working Group and Deputy Lead for Sustainability and University Medical Imaging Toronto at the University of Toronto. She has followed a plant-based diet for over a decade. In this episode we discuss:Climate change and environmental sustainability in medical imaging/radiologyCurrent and future research Tips for sustainable medical and personal practicesTake home messageEpisode Resources:Environmental Sustainability and MRI: Challenges, Opportunities, and a Call for ActionLetter to the Editor: Radiology Action for Climate ChangeClimate Change and Sustainability. RadiologyClimate Change and Radiology: Impetus for Change and a Toolkit for ActionUniversity of Toronto, Medical ImagingCanadian Association of Radiologists Sustainability Working Group Dr. Kate Hanneman's Socials: Instagram: @katehanneman X/ Twitter: @katehanneman, @imagingtoronto & @UofTMedImPlant-Based Canada's Socials:Instagram  (@plantbasedcanadaorg) Facebook (Plant-Based Canada, https://m.facebook.com/plantbasedcanadaorg/) Website  (https://www.plantbasedcanada.org/) X / Twitter @PBC_orgThank you for tuning in! Make sure to subscribe to the Plant-Based Canada Podcast so you get notified when new episodes are published. This episode was hosted by Stephanie Nishi RD, PhD.Support the show

CSAM (Canadian Society of Addiction Medicine) has extended an invitation to our very own Dr. Wip to present their 2023 Lifetime Achievement Award to his mentor, Dr. Shelby. Dr. Wip elucidates the profound influence and enduring impact that Dr. Shelby has had on his journey. Dr. Peter Selby is a Clinician Scientist and Senior Medical Consultant at CAMH. He is the Interim Vice-Chair of Research for the Department of Family and Community Medicine and holds the Dr. Barnett & Beverley Giblon Professorship in Family Medicine Research at the University of Toronto. He is a Clinician Scientist and Director of the Mental Health and Addictions Division in the Department of Family and Community Medicine. He is also a Professor in the Department of Psychiatry and in the Dalla Lana School of Public Health at the University of Toronto. He is also a full member of the School of Graduate Studies through the Dalla Lana School of Public Health and the Institute of Medical Sciences at the University of Toronto. Areas of Research Dr. Selby's research focus is innovative methods to understand and treat addictive behaviours and their comorbidities. He also uses technology to combine clinical medicine and public health methods to scale up and test health interventions. His cohort of 280,000+ treated smokers in Ontario is an example. His most recent program of research utilizes a Learning Health Systems approach to investigate how technology enabled collaborative care can enhance the delivery of evidence-based interventions to the patient while providing a more satisfying experience of care for both patient and provider. Dr. Selby has received grant funding totaling over 100 million dollars from CIHR, NIH, and Ministry of Health, and has published 38 research reports prepared for the government. Dr. Selby mentors residents and faculty from a variety of disciplines. He is a sought after speaker for various topics including addictive disorders, motivational interviewing, and health behavior change at individual and system levels. Publications Dr. Selby has published over 150 peer-reviewed articles, 37 books or book chapters, and 125 international presentations. https://csamconference.org/ Featuring addiction psychiatrist Dr. Wiplove (Wip) Lamba, addictions case manager and former addict Jean-Paul (JP) Michael, along with their guests discuss all things related to substance use, addiction, addiction medicine, psychotherapy, harm reduction, treatment and recovery. Wip and JP share their motivation, curiosity, and passion for their craft. JP works on a daily basis in a renown inner city hospital in Canada's largest city. This work is separate from Wiplove's clinical and academic work. The content should not be taken as direct medical advice or clinical instruction.

In this conversation, Ibukun Abejirinde, a scientist at the Institute for Health System Solutions at Women's College Hospital, and Assistant Professor at the Dalla Lana School of Public Health at the University of Toronto, and an AMS Healthcare Fellow in Compassion and AI chats with Terence Tang, a General Internal Medicine Physician at Trillium Health Partners, a Clinician Scientist at the Institute for Better Health and an AMS Healthcare Fellow in Compassion and AI. They discuss social determinants of health, health inequities, and digitally enabled models of care. Ibukun Abejirinde is an Implementation and Evaluation Scientist who works with policymakers, patients, community organizations, and researchers to find practical solutions to persistent and emergent problems in healthcare. Her research focus on innovative models of care that use digital technology. Specifically, how they impact health equity and health service delivery. Ultimately, her goal is to improve access to high-quality care for everyone, irrespective of where they live or where they are from. Dr. Abejirinde is currently a Scientist at the Institute for Health System Solutions, Women's College Hospital where her work informs the implementation, sustainability, and expansion of virtual care programs within and beyond Ontario. She is also an Assistant Professor (Status) at the Dalla Lana School of Public Health, University of Toronto. As a 2022 AMS Healthcare Fellow in Compassion and AI, her study is being conducted in partnership with three community partners, with the aim of understanding how immigrants and refugees to Canada experience virtual care and digital health compassion.  AMS Research Team Members - Ibukun Abejirinde (Scientist/Principal Investigator) - Emily Ha (Research Associate and PhD candidate, UoT) - Marlena Dang Nguyen (Equity Specialist and Research Coordinator) - Kyla Gaeul Lee (PhD student, UoT) - Isabelle Choon-Kon-Yune (Research Assistant) - Mohaddesa Khawari (Peer Researcher) AMS Study Research Partners 1. FCJ Refugee Centre Website 2. Crossroads Clinic, Women's College Hospital Website 3. Access Alliance Multicultural Health and Community Services Website AMS Research Advisory Team Members 1. Dr. Vanessa Redditt 2. Denise Zarn 3. Dr. Onil Bhattacharyya 4. Dr. Jay Shaw Readings and Resources 1. Abejirinde IO, Ha E, Nguyen MD, Kaur D, Redditt V. Beyond technology: Digital Health Compassion for Canadian Immigrants and Refugees. January 2023. Volume 19, Number 4. Canadian Diversity (pg. 10-12). https://km4s.ca/2023/04/beyond-technology-digital-health- compassion-for-canadian-immigrants-and-refugees/ 2. Panel Discussion. Digital Health Imperative - Equity and System Transformation. Access Alliance Multicultural Health and Community Services, Canada. All Staff Professional Development Day. November 2022. Summaries- blog and video clip 3. Hankivsky, O., Grace, D., Hunting, G. et al. An intersectionality-based policy analysis framework: critical reflections on a methodology for advancing equity. Int J Equity Health 13, 119 (2014). https://doi.org/10.1186/s12939-014-0119-x 4. Hodges BD, Paech G, Bennett J. Without Compassion, There Is No Healthcare: Compassionate Care in a Technological World. Edited by Brian D. Hodges, Gail Paech, and Jocelyn Bennett. McGill-Queen's University Press; 2020. 5. Crenshaw K. Demarginalizing the Intersection of Race and Sex: A Black Feminist Critique of Antidiscrimination Doctrine, Feminist Theory, and Antiracist Politics [1989]. In: 1st ed. Routledge; 1991:57-80. doi:10.4324/9780429500480-5 6. Singh P, King-Shier K, Sinclair S. The colours and contours of compassion: A systematic review of the perspectives of compassion among ethnically diverse patients and healthcare providers. Van Bogaert P, ed. PLoS ONE. 2018;13(5):e0197261. doi:10.1371/journal.pone.0197261 Want to connect? Are you attending the Metropolis Social Determinants of Health Conference in Gatineau Québec (October 2-3 2023)? Join our roundtable dialogue 11:00am - 12:15pm on October 2 nd titled “Reimagining Compassionate Healthcare for Immigrants: Lessons learned from Virtual Care” Contact: Ibukun.abejirinde@wchospital.ca   Terence Tang is a General Internal Medicine physician at Trillium Health Partners located in Mississauga, Ontario, and a Clinician Scientist at the Institute for Better Health.  He has training in informatics and has a passion of using digital technology to improve care delivery and population health.    Links:   Institute for Better Health (https://www.instituteforbetterhealth.com/)    A tool to capture social determinants of health by Upstream Lab (https://upstreamlab.org/project/spark/)

The fourth Season of the National Institute of Neurological Disorders and Stroke's Building Up the Nerve podcast, where we discuss the unwritten rules, or “hidden curriculum,” of scientific research at every career stage. We know that navigating your career can be daunting, but we're here to help—it's our job!In episode 6, we talk about conducting research as a clinician-scientist, including the different paths to research as a clinician and what a clinician-faculty position can look like.Featuring Erika Augustine, MD, Associate Chief Science Officer, Kennedy Krieger Institute; Edjah Nduom, MD, Associate Professor, Emory University; and Audrey Brumback, MD, PhD, Assistant Professor, The University of Texas at Austin.ResourcesNINDS Institutional Awards for Clinician-Scientists, such as T32 and K12 Programs: https://www.ninds.nih.gov/funding/training-career-development/institutional-grants For example, Dr. Augustine is on the leadership team of the Child Neurologist Career Development Program-K12 at Kennedy Krieger Institute: https://www.kennedykrieger.org/cncdp-k12NINDS Career Development Awards: https://www.ninds.nih.gov/funding/training-career-development/career-development-awards OPEN Stage Webinar: Clinician Scientist Clinic – Overview of NINDS Funding Opportunities and Q&A: https://www.ninds.nih.gov/news-events/events/open-stage-webinar-clinician-scientist-clinic-overview-ninds-funding-opportunities-and-qa NIH Office of Clinical Research Training and Medical Education: https://clinicalcenter.nih.gov/training/index.html The World Wasn't Ready for You by Justin C. Key: https://www.harpercollins.com/products/the-world-wasnt-ready-for-you-justin-c-key?variant=41016598036514  Transcript available at http://ninds.buzzsprout.com/.

Dr Luca Cocchi is a Group Leader and Associate Professor at QIMR Berghofer, who is currently working on ways to improve TMS for its usage in OCD treatment. Dr Philip Mosley is a Psychiatrist and Clinician-Scientist at QIMR Berghofer, where he is currently researching DBS for treatment-refractory OCD.  In this episode, Phillip explains deep brain stimulation (or DBS) and how it's being used to treat severe and treatment-resistant OCD. Phillip and Luca also discuss the outcomes of recent clinical trials and explain how accessible these treatments currently are for Australians.  This episode is part two of our two-part conversation with Luca and Phillip. Check out our last episode to hear more about the neuroscience behind OCD, and the use of TMS for OCD treatment.   Connect: https://www.melbournewellbeinggroup.com.au/ http://www.drcelingelgec.com.au/ This show is produced in collaboration with Wavelength Creative. Visit wavelengthcreative.com for more information.

You might think becoming eternally young isn't possible but scientists from Cornell University, the University of Oxford, the University of Cambridge, and Cancer Research UK, are actively exploring how to reverse the ageing process. Dr. Meng Wang, Clinician Scientist in Haematology at Cornell University joins Jonathan to discuss.

Dr Luca Cocchi is a Group Leader and Associate Professor at QIMR Berghofer, where he is currently working on ways to improve TMS for its usage in OCD treatment. Dr Philip Mosley is a Psychiatrist and Clinician-Scientist at QIMR Berghofer, who is currently researching DBS for treatment-refractory OCD. In this episode, Luca and Phillip explain the neuroscience behind OCD, as well as what treatment-resistant OCD means and why it happens. Plus, Luca breaks down the exciting possibilities of transcranial magnetic stimulation (or TMS) for OCD. This episode is part one of our two-part chat with Luca and Phillip. Keep an eye out for part two, where Luca and Phillip dive deeper into the treatment possibilities of TMS and DBS.   Connect: https://www.melbournewellbeinggroup.com.au/ http://www.drcelingelgec.com.au/ This show is produced in collaboration with Wavelength Creative. Visit wavelengthcreative.com for more information.

Today I sit down with Dr. Michael Fralick, who is a Clinician-Scientist at the University of Toronto to talk about locuming as a physician.Mike and his brother, John Fralick, host the Rounds Table podcast, bringing summaries of the most relevant randomized controlled trials to practicing physicians.Table of Contents:My opinion on the benefits of locuming (0:48)Dr. Mike Fralick's background (4:37)Mike's experiences locuming to date (5:45)Where to locum, how to sign up for locums (7:48)The motivation behind locuming (9:38)The key benefits of locuming (11:03)Time & geographical freedom through locuming? (14:34)The key negatives/challenges of locuming (16:05)Finances of locuming (19:16)Billing on locums (22:08)What expenses are covered on a locum? (23:39)Tax implications for some academic physicians (24:18)Locum contracts (26:09)Mike's "Rounds Table" podcast, elective for residents in Sue St. Marie (27:36)Mike's Links:https://healthydebate.ca/special-series/podcasts/https://twitter.com/FralickMikeYatin's Links:https://www.linkedin.com/in/yatin-chadha-29074b109/beyondmdpodcast@gmail.combeyondmdpodcast.comhttps://www.youtube.com/watch?v=yAEU2ElLq70

Many women complain that physicians are reluctant to treat menopause with the full range of available therapies, often dismissing symptoms as 'natural' and something to be endured. A review article in CMAJ  finds that physician fears around menopausal hormone therapy and lack of knowledge regarding treatment options often impede patients from receiving treatment.On this episode, Drs. Mojola Omole and Blair Bigham speak with Dr. Iliana Lega, the lead author of the review entitled "A pragmatic approach to the management of menopause." Dr. Lega is a Clinician Scientist and Endocrinologist at Women's College Hospital in Toronto. She encourages physicians to update their therapeutic understanding of menopause and to initiate conversations with women about the symptoms of perimenopause as they enter their forties.Drs. Omole and Bigham also hear from Janet Ko, the co-founder and president of the Menopause Foundation of Canada. She shares her personal experience of receiving a delayed diagnosis of perimenopause and the impact of hormone replacement therapy on her well-being. Ms. Ko also shares the results of the foundation's study on women's experience receiving care for menopause, and reports that 72 percent of women found medical advice to be unhelpful or only somewhat helpful.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on Twitter @BlairBigham and @DrmojolaomoleTwitter (in English): @CMAJ Twitter (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Why is Schrödinger's Cat so controversial? Dr. Katie Mack, Hawking Chair in Cosmology and Science Communication at the Perimeter Institute for Theoretical Physics What are the implications of Trump's charges? Dr. Thomas Nichols, Professor Emeritus of National Security Affairs at Harvard University and Contributing Writer at The Atlantic The closure of Highway 14 is taking a toll on Tofino Dan Law, Mayor of Tofino How will $20 million help St. Paul's ‘Road to Recovery?' Dr. Seonaid Nolan, Head of Providence Health Care's Division of Addiction at St Paul's Hospital and a Clinician Scientist with the BC Centre on Substance Use Why do we find AI so creepy? Dr. Karl MacDorman, Associate Dean of Academic Affairs and Director of Informatics and Artificial Intelligence at the Luddy School of Informatics, Computing, and Engineering  Learn more about your ad choices. Visit megaphone.fm/adchoices

How will $20 million help St. Paul's ‘Road to Recovery?' Dr. Seonaid Nolan, Head of Providence Health Care's Division of Addiction at St Paul's Hospital and a Clinician Scientist with the BC Centre on Substance Use Learn more about your ad choices. Visit megaphone.fm/adchoices

Age is a main factor when determining cancer care. In this ASCO Education podcast we speak to one of the top leaders in treatment for older patients who has also credited mentorship as a foundation for his career. Dr. Hyman Muss describes his childhood in Brooklyn, serving as a general physician for troops in Vietnam (6:18), the doctor who influenced his choice of hematology and oncology (7:48) and creating one of the first geriatric oncology fellowships in in the country (21:58).  Speaker Disclosures Dr. David Johnson: Consulting or Advisory Role – Merck, Pfizer, Aileron Therapeutics, Boston University Dr. Patrick Loehrer: Research Funding – Novartis, Lilly Foundation, Taiho Pharmaceutical Dr. Hyman Muss: None More Podcasts with Oncology Leaders  Oncology, Etc. – Devising Medical Standards and Training Master Clinicians with Dr. John Glick Oncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 1) Oncology, Etc. – In Conversation with Dr. Richard Pazdur (Part 1) If you liked this episode, please follow the show. To explore other educational content, including courses, visit education.asco.org. Contact us at education@asco.org. TRANSCRIPT Pat Loehrer: Welcome to Oncology, Etc., an ASCO Education Podcast. I'm Pat Loehrer, director of Global Oncology and Health Equity at Indiana University.  Dave Johnson: And I'm Dave Johnson of Medical Oncology at the University of Texas Southwestern in Dallas, Texas. If you're a regular listener to our podcast, welcome back. If you're new to Oncology, Etc., the purpose of our podcast is to introduce listeners to interesting and inspirational people and topics in and outside the world of Oncology. We have an inspirational guest today. Pat?  Pat Loehrer: If you ask anyone who's achieved any level of success and how they've achieved it, most likely they'll mention a number of people who've influenced them along the way. Quite often, these people reflect on their mentors, and after a certain time of accomplishment and reflection, they begin to mentor others. This is very much what our next guest has done. Dr. Hyman Muss has been a mentor to me and to Dave, and he's one of the most outstanding, wonderful people in the world, and we're so excited to have him today.   Dr. Hyman Muss served in the US Army in Vietnam, where he was awarded the Bronze Star Medal. He's an experienced Clinician Scientist, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology at the University of North Carolina School of Medicine, and the Director of Geriatric Oncology Program at the UNC Lineberger Comprehensive Cancer Center Program. His interest in education and research is focused on cancer and older patients, and he is internationally recognized in this area. He's been the co-chair of the Alliance Committee on Cancer and Older Adults and won the BJ Kennedy Award from ASCO in Geriatric Care. His particular interest in research expertise is in the care of breast cancer patients, with a focus on the management of women who are of older ages. He's had a major interest in breast cancer survivorship and long-term toxicity of treatment and also served as the co-chair of the Breast Committee for the Alliance Group. He serves as a mentor for medical students, medical residents, junior faculty, and more recently, his Geriatric Oncology fellows. He served on the Board of Directors of the ASCO Foundation and on the ABIM, the American Board of Internal Medicine, where both Dave and I were privileged to work with him and witness his leadership and his deep breadth of knowledge.  Dr. Muss, thanks for joining us today. Dr. Hyman Muss: What a pleasure to be here. Thank you so much for inviting me. My mother would have loved the introduction.  Pat Loehrer: Well, speaking of that, tell us a little bit. You grew up in Brooklyn, so tell us a little bit about your parents. Your father was a dentist, I think, and your uncle was a general practitioner. So give us a little bit of the early life of Hy Muss. Dr. Hyman Muss: So I grew up in Brooklyn, New York. I was born and bred there. I went to Brooklyn Technical High School. I almost went to Brooklyn College, but I came back and went to Downstate Medical Center, which was just terrific. My tuition was $600 a year, but that's another story. My parents lived in the same neighborhood. My dad was a dentist, so we knew all the people. My uncle was the GP. You came into their office, sat down, and they saw you anytime, day or night, almost 24/7, something we're probably not going back to, but they had a profound influence on me. My uncle, as a GP, used to take me on house calls in Brooklyn when they were done, and he had an old Buick with MD plates. And I would go into these families, and they loved him, and they would give me ice cream and things. Maybe that's what made me a doctor. But it was a terrific and indelible experience. I had terrific parents. In those days, doctors and medical people usually lived in the same neighborhoods as their patients, so they really knew their people well. It was a terrific upbringing. I got to love medicine and have never had a look back. Dave Johnson: So your inspiration for a career in medicine obviously started at home. Tell us more about your formal education. You mentioned your high school education. What about college? And shortly thereafter?  Dr. Hyman Muss: Yeah, well, I went to Lafayette College. I was not the best high school student, but I had good college board scores or whatever they called them then. And I went to Lafayette and I thought I was going to be a chemist, a chemistry major. But I took enough premed courses and I spent a summer in a lab building cyclic ketones. And everybody was outside sitting on the lawn of the campus. And I was in there with all these distillation apparatus, and I said, “I don't think I can do this the rest of my life.” So I applied to medical school, and I got into several medical schools. But my father at that time was dying of metastatic bladder cancer. He had been a heavy smoker, and he was still working as a dentist. He worked until the day he unfortunately died. But I got into Downstate. We lived in Brooklyn, and my uncle, the GP, said, "Hy, you need to come home and help take care of your dad." I'm an only child, so I did. And I had a wonderful experience at Downstate.   Several years ago, I was listening to NPR and heard that one of my professors had won the Nobel Prize. Dr. Furchgott in physiology, one would have never thought. And I had a wonderful education and subsequently got into what was then Peter Bent Brigham in Boston, did my internship and residency there, joined the army and medical school, so I wasn't drafted, it was a program then. And then after first year of residency, I went to Vietnam, worked with an artillery battalion, a mystical experience, but no regrets. And then subsequently came back and did hematology and oncology at Brigham and at what was then the Jimmy Fund and Sidney Farber Cancer Center. And Tom Frei had just come. And I did hematology with a guy named Bill Moloney in Boston at Harvard. I'll tell you, a wonderful man. He was like a surrogate father. My dad had died by then, and I just feel I've had every opportunity to have a wonderful education and terrific mentors along the way. Dave Johnson: So we want to ask you about both of those gentlemen, but I would like to just, if I may, drop back to your experience in Vietnam. What was that like?  Dr. Hyman Muss: Well, I was 27 years old and I was put as the doctor for 500 men in artillery. My job was to take care of the general health of the troops. Fortunately, we didn't have many casualties. It wasn't a front war like my uncle, who was a GP actually in World War II, landed in Normandy about a week later and went all through World War II as a doctor. But Vietnam was an unusual war, there wasn't really a front. So my experience was I would go out to fire bases, which were units of about 100 men in the jungle, go out three days in a week in a helicopter, do sick call, check people. I dealt with really alcohol problems, unfortunately, a lot of drug problems. You had young people with really not a lot to do during the day, nothing much to do, and no real goal of being there. I did that for a while, and actually, the reason I got the Bronze Star was because I set up– It was nothing like standing in front of a machine gun. I'm not that kind of brave guy, but I set up a drug amnesty program so I got a lot of support from our regular field people to do this, so we didn't have to keep sending kids home with dishonorable discharges. And I learned a lot. I think we were reasonably successful. I learned a lot about artillery. I think overall it was a great experience in my life. Dave Johnson: Tell us how your interest in hematology and oncology originated. Where did that come from?  Dr. Hyman Muss: When I was an intern at the Brigham, Dr. Moloney was a very famous Harvard professor. He had studied war casualties after Hiroshima, he was one of the people that found the Philadelphia chromosome in CML. He was a guy that rounded on every single one of his leukemia patients every day. So I was an intern. So in those days I would go and see all the hematology people rounding because all the acute leukemia patients and all the serious cancer patients were right on the floors, right on the wards. We had 17-bed wards, and then we had some private rooms. And he loved what he did. And before I left for Vietnam, we didn't have Ara C and daunomycin. So every leukemia patient I saw died. This is '68 to '70. Yet we tried all these different regimens. Occasionally you got someone who did well for six months, a year. But his bedside manner was absolutely wonderful to me. He knew all the patients. He'd ask them about where they lived in Boston. His humanism was terrific, and yet I loved the diseases he treated. The stakes were high. We didn't have good treatment, and I decided that that's probably what I want to do.   So when I was in Vietnam, I applied and got back in the Hematology Fellowship and came back and did that. I saw Ara C and daunomycin. I gave the chemotherapy to them, and he'd say, "Go up and treat Harry Smith with Ara C and daunomycin." I had the syringes in my pocket, guys. Forget about hoods and mixing. And I'd go up and treat them and the marrow would be gone within four or five days. I did a bone marrow. They published their regimen in the New England Journal called COD, C-O-D because they also gave vincristine. So it was cytarabine, vincristine, and daunomycin, the COD regimen. It fit Boston. And I saw it was like the emergence of cisplatin after Larry Einhorn. You saw people that never survived going into remission and I saw some remissions in AML and it cemented it.  About my second year of residency, we had a child. I was running out of money. I was being paid $6,000 a year and I had the GI Bill. I went into Dr. Moloney and he talked with Dr. Franny Moore, who was head of surgery at the Brigham, and they made me the Sidney Farber Research Fellow, doubled my salary and I had to go to the Jimmy Fund and see cancer patients. And it so happened that was when Tom Frei came to Dana-Farber. And so I started rounding with Dr. Frei and seeing those patients. And I think the first day I walked in, I knew I wanted to do more than just leukemia because I saw groups of patients with every disease. We treated everybody with CMFEP, it didn't matter what cancer they had. And I just loved it and said, "My God, there's so much we can learn. What a great career." And so that got me into the oncology portion.   And then I was offered to stay at Harvard. They were going to make me an assistant professor, but they wanted me to do lab work. And I knew my personality, it just wasn't for me. I worked with a lovely guy named Frank Bunn, one of the world's great hem guys in his lab, and he's still a close friend in his 80s. And he told me one day, he said, "Hy, I don't think the lab is for you." And he actually helped me get my first job at Wake Forest University, which turned out to be wonderful. So that's how I ended up with my circuitous in HemOnc. And it's really from great mentors, it's from Bill Moloney, it's from Tom Frei, Dave Rosenthal, tons of wonderful people along the way that not only taught me a lot, but they seemed to love what they do, which is a gift in life to love what you do and love the people you're doing it with. They instilled that in me. Pat Loehrer: From there you went to Wake Forest and there's a couple of colleagues down there, I believe, that inspired you, Charlie Spurr and Bill Hazzard, who was the founding founder of geriatrics. Tell us about that experience and how'd that shape your life.  Dr. Hyman Muss: I was looking for a clinical job and I looked at Rochester, and I got snowed in one night in Wake Forest, and I said, “Where's the contract?” And I signed it. And my mother, who was living in New York City, didn't know where North Carolina was. My mother was from a family, was born over a candy store in Greenwich Village, and said, “Where are you going?” And then I showed her where it was, and she says, “They're going to kill you down there.” And it turned out to be one of the best decisions of my life. My wife Loretta, who both of you know so well, we got out of our VW with our dog and our daughter when we moved here, and VW bug, by the way, not a van, and she cried. It turned out it was one of the best opportunities.  Charlie Spurr was an iconic oncology leader. He actually did some of the early work on nitrogen mustard in Chicago during the war, the first chemotherapy drug. He was a terrific leader. He had patients programmed in on those IBM punch cards. He had little cards for the protocols, CMFEP, CMF, AC on little laminated index cards. I learned so much from him, and he was to me, great leaders and great mentors morph from things they do themselves to teaching other people, and whose brains have the ability of having the same dopamine shot when you see one of your fellows or young faculty present a wonderful study as you do. And your brain isn't saying, “I wish I was up there.” It's saying, “Isn't this so cool that this young man or woman or fellow or medical student is doing such a wonderful job?” And I had something to do with providing the soil for this seed to grow. That's the kind of guy he was. And so it was wonderful there.  And as I moved on, we got a new Chief of Medicine, Bill Hazzard. And I still hear from Bill on rare occasions, but Bill was one of the first geriatricians in the United States. He wrote the textbook, and his wish was that all the faculty and all the specialties get involved in a geriatric project. And so I had all those little index cards, and I looked and saw how many older people with metastatic breast cancer we'd given chemotherapy to. And these were little protocols, nothing like the protocols today, no 50-page consent forms, 50 pages of where your data is stored. They were like, here's the treatment, here's the dose mods. And I looked at those 70 patients with one of our residents, Kathy Christman, she may be retired now, but in any event, we wrote a paper and showed the old people did as well as the young with breast cancer. And we published it in JAMA. And it's one of the few papers in my career, I got no reviewers. They accepted the paper. I got no reviewers. So because I'm from Brooklyn, and my English is not what it should be, I had my friends read it to just make sure I didn't say anything egregious. But it got published and the next thing I know, my friends in medical oncology in the state were calling me. They said, “I got a 75-year-old woman here.” I'm saying, “Guys, I just wrote this paper. I really don't know anything about older people.” But slowly, with Bill Hazzard and others, I got more and more interested. I started reading about Geriatrics and I ended up making it a focal point of my career. It was kind of happenstance. And Bill was a wonderful mentor.  And then as I subsequently moved on, I worked with terrific people like Harvey Cohen, Lodovico Balducci, and Martine Extermann, all of them heavily involved with ASCO over the years as well, and B.J. Kennedy. They were wonderful to work with. And BJ was inspirational because BJ would get up at an ASCO meeting and he'd say when he saw the age cut off, he'd say, “How come you didn't let old people on that study? There'd be 1000 people in the audience.” And so he really was a great mentor. And I had the bittersweet opportunity of writing his obit for JCO years ago and kept up with his family a few years, but he was a wonderful man. Dave Johnson: I'm just reflecting on the fact that today, patient registries are sort of mainstream, but certainly in the ‘70s, ‘80s, even into the ‘90s, having a list of patients with a particular disorder seemed almost novel in many respects. And to have that was a godsend.  Dr. Hyman Muss: It was a godsend. I still remember those little file cards. And he called it the Oncology Research Center and it was a godsend. And you've got to remember, this is like ‘74, ‘75, it's a long time ago. Dave Johnson: So many of our listeners may not be as familiar with Wake Forest as they are with Duke and North Carolina, the other medical schools located there. But you were at right at a point where I mean, it was one of the top oncology programs in the country at that time. Still is, I don't mean to diminish it, but there was a who's who of people there at the time. And you were also involved in creating, I think, one of the first cooperative groups of sorts. It was the Piedmont Oncology Group. Tell us about that.  Dr. Hyman Muss: Oh, yeah, well, that brings back memories. So the NCI at that time wanted to get more, I think, rural and other smaller places involved in research. And they put out an RFA to form like regional cooperative groups. And we formed the Piedmont Oncology Association, the POA. We actually did well for a few years. We wrote some really good studies. We got one or two New England Journal articles. I worked with all the people, mainly in the community, community docs who would go on, and put people on the protocol. I mean, I looked at all the X-rays and scans in a lot of these patients myself as part of the studies we did. And it turned out to be a wonderful organization and it's still run today by Bayard Powell, who is one of our terrific fellows who's the head of Oncology at Wake Forest.  But after a while, we just couldn't compete with CALGB, of which I was a member of also, and ECOG and SWOG, even North Central Group, which was kind of formed in a similar venue, eventually merged. So we did a wonderful job for a while but the truth is we just didn't have the manpower to write studies for every disease site. So eventually we kind of petered out as a clinical trials group. But it's been maintained for educational programs and it's really served as a good resource for a lot of good education for the community oncologists who give most of the care in this country in the state. So it's been good. I think Pat kind of exceeded us with HOG, the Hoosier Oncology Group, which was in a similar vein. But it was a great experience and it was all Dr. Spurr, who thought of doing this and built it.  Dave Johnson: Certainly, it was inspirational in many people in and outside of Wake Forest. So with such an idyllic life, what in the world possessed you to move north to Vermont?  Dr. Hyman Muss: Well, you get this urgent life. You want to be a leader, you want to be a chief. Now, I tell younger people, if they love what they do, don't do it. So I got a wonderful opportunity at the University of Vermont to go up there and be Head of HemOnc. Chief of Medicine was a terrific guy, Burt Sobel. The university at that time, at one time it had a wonderful Oncology program. It had a federally funded cancer center with Irwin Krakoff and Jerry Yates, two other iconic guys. I don't know what the politics were but it had lost a tremendous amount of faculty, especially its clinical faculty, and they needed to rebuild it. And I went up and I thought, “Well, I'm in my 50s. This is going to be a great opportunity. If I don't do it now, I may never get the chance.” So I went up there and actually, it was a great opportunity. We hired terrific people. We got CALGB and we participated. We had actually a very good accrual for a small place and we had a very small but very effective cancer center. So it turned out to be a really good experience.  I worked with wonderful people. I recruited some wonderful people. But over time, the issues of the business of medicine, all the issues that happened, I'm saying I'm kind of losing my focus on clinical care and clinical trials, which I love to do. I don't need to tell either of you. I mean, Dave, you've been chief and department chair and Pat has run cancer centers. After a while, the administrative tasks just were so overwhelming and I didn't enjoy them, that I said, “I've got to get back in some type of more clinical focus.” And that's when I decided to look around and fortunately found what's turned out to be a dream job at UNC.  But it was a time of life. Maybe my ego got in the way of my logic. I don't regret it. I met and I think we rebuilt a wonderful clinical program. But you realize some of the resources of big places with-  we never had the research infrastructure to hire a lot of people and get big programs going on and great translational programs, just didn't have the funding. But it was great, and I have no regrets. And I learned how to tolerate the cold weather. And I have a lovely daughter, Sarah, who still lives up there. So we get back occasionally. And I've kept up with a lot of the people there. There are some wonderful people at UVM.  Pat Loehrer: From there, though, you were pulled down to North Carolina, where you've, again, built an incredible breast program there is outstanding. But you've created a Geriatric Oncology program, one of the first geriatric fellowships in oncology in the country. So tell us a little bit about that and what you feel may be your legacy is there at North Carolina.  Dr. Hyman Muss: Well, I had the opportunity over the years when I was at Wake, really, I got to know Shelley Earp, who's our cancer center director. I think maybe you were close to him, Pat. The longest surviving cancer center director on the planet, or among them. And we were good friends. And North Carolina's legislature actually gave the University of North Carolina substantial funding to improve cancer care in North Carolina, not just research. And so I had talked with Shelley about maybe moving, and because of the generosity of the state, really, he was able to really get me going, start a Geriatric Oncology program. And what I wanted to do was develop trials. As Dave says, I built a registry in 2009 here for older cancer patients using geriatric assessment. I have 2000 patients, which has been a resource for all types of faculty and fellows, and students to write papers. But I was able, with the support, to do things like this right from the get-go. And plus, I joined probably one of the best breast groups on the planet with Lisa Carey and Chuck Perou, and Larry, terrific people, Claire Dees. I had great luck in doing this, so I was able to really focus, get great support from my colleagues to build studies focusing on older people.  And then I had the great fortune of meeting Ned Sharpless, our prior NCI director. And Ned is one of the world's great aging biologists. And I don't mean aging as an adjective, he's really been a master on why we age, the biology of aging, cell senescence. So Ned taught me all about cell senescence and the mechanisms, especially the gene expression p16, which is like our own CDK inhibitor. And so I was able to start using his lab, collect samples, treat people with chemotherapy, follow them off with geriatric assessment. It was a great opportunity to do that here, and we got a lot of studies going and we showed what the pediatricians have known for years, that chemotherapy dramatically ages people, not just children, but adults. But it also allowed me to work with my colleagues in lymphoma and lung cancer to do little studies along the way.  And we eventually then built a T32 program. We got a T32, which we're kind of completing now our first five years to train oncology specialists in geriatrics. So the way we do it is they can be surgical oncologists, GU, we had a GYN oncologist, medical. With their HemOnc training, they do a year where they work with the geriatricians, so they go on geriatric inpatient service for a month and they really learn about older people. And part of it is a project. So we've been able to build that and develop a lot of programs with that. And I should say we've been very successful with mentorship and with ASCO support for things like YIAs, the late and great Arti Hurria, who absolutely an amazing woman. Some of her legacy at ASCO, the YIAs, and things. We've been successful in applying for some. So we've been able to build a whole spectrum of med and hematologists. We have an interest in Myeloma and AML focusing on older people. We've been able to build a whole team approach, including translational projects related to older people. And it's just been a great opportunity, and hopefully, my legacy here will be, too, and I'm working on it.  We have a wonderful guy, Bill Wood, who is very effective and has built this incredible coaching program to continue this legacy. Like many of us in this field, we are bothered because we all know the stats, we all know that first slide of the demographics of cancer, and yet it's been very hard in our culture to provide a lot of the services and build the clinical trials we need to best care for older people. It's still a major problem in this country. So as I cut back on my clinical care, I'm going to still advocate to try to improve the care of older people. Do geriatric assessment, build it into your clinical programs, get your hospitals to support you, convince them, build business plans, et cetera. And hopefully, that'll be my ultimate legacy, that we've made greater awareness of the older people, other than the usual stats, and we're really trying to care for them in a much more global sense, in a much more holistic sense than we've done. I hope we'll be successful. It's a slow haul, but we've got lots of great young people coming up through the pipelines, ASCO has been a great player in this. Many of you know people like Supriya Mohile and William Dale, Heidi Klepin, people, the next generation that's going to keep building this. So I hope the legacy will be that we get more buy-in, more interest, more trained people in other oncology-related subspecialties RadOnc, SurgOnc that will really focus on the care of older people. Dave Johnson: I don't think there's any doubt that that will be a part of your legacy Hy, but I think your legacy will be much broader than the world of geriatric oncology. Your mentorship leadership, your clinical skills, your educational capabilities, all of that will certainly last for many, many years in the future.  Well, I don't want to bring up a touchy topic, but you yourself are geriatric and we're wondering what your plans are for your semi-retirement. I recognize you're not retiring, but what do you like to do outside of medicine? Dr. Hyman Muss: I'll tell everybody who's interested in hearing this. On Tuesday, I had my 80th birthday.  Dave Johnson: Congratulations.  Dr. Hyman Muss: And I think I'm one of the most blessed guys. I'm pretty healthy. I married up -  my wife Loretta, who both of you, Pat Loehrer and Dave Johnson, know well.  Dave Johnson: Yeah, you definitely married up.  Dr. Hyman Muss: Yes. It's really carried me most of my life. She's great and so she flew up our three kids and we celebrated and I'm very fortunate. I have the enthusiasm and strength to do more clinical medicine. But I think the time has come for me to cut back my clinical medicine, so I'm going to do that in June. The hardest thing I've done is say goodbye to so many of my patients here.  We've been blessed. We have a lovely family. We're pretty close. I'm never bored, probably you two know well, I love to do things like fishing, outdoor stuff. I've really gotten into woodworking, so I'm not going to be bored. But there will be a small piece out of me when I walk out of that clinic in June. I know that and my two close psychiatry friends think it's going to really be a hard fall, but I don't think so. I still have some grants. In fact, I'm working with a fellow in City of Hope, Mina Sedrak, who's been very involved in ASCO, too. We are hoping to get an R01 looking at senolytic drugs that may prevent aging, and exercise in older women with breast cancer to see if we can reverse the trends of chemo. So my brain is still on that stuff, but the clinical care is going to be tough.  I had a note and for some reason, we talked about so many things. I wanted to mention that one of my great opportunities was joining the CALGB and then the Alliance and getting the support of Dr. Schilsky, Rich Schilsky, who's been one of the icons of ASCO to build cancer in the elderly working group with Dr. Harvey Cohen at Duke. And Harvey is one of the world's great geriatricians. And using that to get studies done, to incorporate studies with Arti Hurria on geriatric assessment, and really have it as a place where a lot of younger investigators could get started on a career in geriatric oncology. And that was really a great opportunity. It was kept on by Dr. Bertagnolli, who now is our NCI director, and I think was really the first group to really give good support for this. Dave Johnson: So we want to thank you very much for being our guest today.  We also want to thank our listeners of Oncology, Etc. This is an ASCO Educational Podcast where we talk about oncology medicine and much more. So if any of our listeners have an idea or a guest they would like for us to interview, please email us at education@asco.org. To stay up to date with the latest episodes and explore other educational content, visit ASCO's website at education.asco.org.   Thanks again for being our guest, Hy.  Dr. Hyman Muss: My pleasure. Thank you so much. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Enduring CME will expire on 6/26/2025 Speaker: Jeffrey Popma, MD Vice President and Chief Medical Officer, Structural Heart, Coronary and Renal Denervation, Medtronic Professor of Medicine, Emeritus, Harvard Medical School, Boston No disclosures Objectives: • Review the critical value of clinician investigation in the discovery of medical devices to serve unmet patient needs. • Discuss the risks and benefits of transcatheter aortic valve replacement in patients with severe aortic stenosis. • Outline the clinical outcomes associated with transcatheter treatment of patients with symptomatic, severe mitral regurgitation with edge-edge repair and other advanced therapies. Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

In collaboration with ROESCG, we introduce a new series, Cancer Careers! Today we're talking with Dr. Alex Louie, a Radiation Oncologist at Odette Cancer Centre and Clinician Scientist at the University of Toronto. He takes us through his love of music, his later found love of answering interesting and practice changing clinical questions, and his tips to stay resilient through a career in medicine. Please provide us feedback on the episode! 

In this episode with Dr Jane Thornton we discuss what the latest evidence says about adapting training advice for the menstrual cycle of women and oral contraceptives and whether the menstrual cycle affects injury risk. We also cover the role of sleep and injury risk, and how this can be affected across the lifespan for women specifically due to hormones. Finally we cover the gaps in the research around specific populations of women e.g. during pregnancy and why this is a difficult topic to study. Dr. Thornton is a Canadian Research Chair and Clinician Scientist specialising in long-term athlete health, female athlete health, and physical activity in the prevention and treatment of chronic disease. She is an Assistant Professor in the Department of Family Medicine, with cross appointments in the Department of Epidemiology & Biostatistics and School of Kinesiology.  If you like the podcast, it would mean the world if you're happy to leave us a rating or a review. It really helps!Our host is @James_Armstrong_Physio from Physio Network

For this week's episode, Sinai Health System's Dr. Bjug Borgundvaag details their counteraction against rising mental health issues and addiction problems. From medical facilities to personnel's adaptability to community-based interventions, we'll have you engaged in this topic. So, listen to this meaningful conversation to help your community and spread awareness!Key takeaways to listen forWhat does “chair” means in emergency medicine addiction and mental health, and how it benefits the general communityThe alarming rise of mental health emergencies and substance abuse casesA great way to help emergency physicians cater to mental health and addiction problemsInspiring stories of recovery from substance addictionHow to engage with a mentally distressed person and substance dependentsResources mentioned in this episodeLCBORapid Access to Addictions Medicine (RAAM)Become a champion of mental health by making a donation. Click this link below to support our mission: https://give.supportsinai.ca/fundraisers/codyyeh/say-yeh-to-positive-mental-healthAbout Dr. Bjug BorgundvaagDr. Bjug Borgundvaag is the Director of the Schwartz/Reisman Emergency Medicine Institute (SREMI) at the Sinai Health System, and a Clinician Scientist in the Department of Family and Community Medicine, University of Toronto, where he holds the rank of Associate Professor. He obtained his PhD in pharmacology prior to attending medical school, and is the Chair of the Pharmacy and Therapeutics Committee at Sinai Health. He has been involved in a wide variety of ED related research projects including antibiotic and opioid prescribing, and the management of alcohol withdrawal. He recently Co-Chaired the Health Quality Ontario quality standards committee for opioid prescribing in acute pain, and the Ontario e-CTAS Evaluation Committee. Dr Borgundvaag has practiced emergency medicine at Mount Sinai Hospital in Toronto since 1995.Connect with Dr. BjugWebsite: Schwartz/Reisman Emergency Medicine Institute (SREMI) | Mount Sinai HospitalFoundation: Sinai Health FoundationTo sign up for our monthly newsletter, visit our website at www.hiefire.com and connect with us through the social media accounts below!Facebook Page: High Income Earners FIREFacebook Group: High Income Earners F.I.R.E.Instagram: @hie_fireSponsorsBonavest CapitalTo learn more about building passive income through real estate syndications, visit www.bonavestcapital.com.Say YEH Stock OptionsLooking for ways to generate consistent cash flow and accelerate your journey to financial freedom? Visit www.codyyeh.com for more information!

Welcome back Rounds Table Listeners! We are back this week with a special podcast episode! Dr. Justin Boyle sits down with Dr. Jennifer Flemming, a Clinician-Scientist and Gastroenterologist at Queen's University, to chat about portal hypertension and the Baveno 7 Guidelines! Questions? Comments? Feedback? We'd love to hear from you! @roundstableThe post Episode 55 – Portal Hypertension for the Internist with Dr. Flemming appeared first on Healthy Debate.

Welcome back Rounds Table Listeners! We are back this week with a special podcast episode! Dr. Justin Boyle sits down with Dr. Jennifer Flemming, a Clinician-Scientist and Gastroenterologist at Queen’s University, to chat about portal hypertension and the Baveno 7 Guidelines! Questions? Comments? Feedback? We'd love to hear from you! @roundstable The post Episode 55 – Portal Hypertension for the Internist with Dr. Flemming first appeared on Healthy Debate. The post Episode 55 – Portal Hypertension for the Internist with Dr. Flemming appeared first on Healthy Debate.

In our first episode of 2023, we delve into Hepatocellular Carcinoma, discussing the relevant investigations, current treatment modalities, as well as upcoming treatment possibilities.Joining us today, are Dr Evelyn Wong, Associate Consultant Oncologist, and Dr Chen Kaina, Senior Resident Gastroenterologist and Clinician Scientist, to share their perspectives on the management of hepatocellular carcinoma.  With the endemicity of Hepatitis B in Singapore, together with the rise of Metabolic Associated Fatty Liver Disease, Hepatocellular Carcinoma is something that we should be familiar with. 

In last week's episode I spoke with award-winning Clinician-Scientist, and 40+ year University of British Columbia Endocrinology Professor. Dr. Jerilynn Prior, about the Paradox of Perimenopause. Dr. Prior's research and innovative concepts has shown that progesterone must be in balance with estradiol for wellbeing and fertility during the premenopausal years and that progesterone decreases menopausal Vasomotor Symptoms of hot flashes and night sweats, and increases bone formation. In this second conversation with Dr. Prior, we look at aging and how our hormones, or lack there of, play a key role in many of the problems which we consider to be part of aging. We discuss her 5 top strategies for healthy aging. Avoid falls and therefore fractures, Maintain heart health, Treat vasomotor symptoms, Get a good night's sleep, and maintain relationships and a sense of community. To learn more about Dr. Prior's work. www.cemcor.ubc.ca Twitter: @cemcornew Facebook: Centre for Menstrual Cycle and Ovulation Research (https://www.facebook.com/cemcor.research) To discover how to Reset Your Aging Blueprint and create your own roadmap to living younger as you grow older, you can schedule a free Discovery Call with me. Order your copy of Growing Older Living Younger: The Science of Aging Gracefully and The Art of Retiring Comfortably here and join our private Growing Older Living Younger Community, to meet people, who like you, are discovering and sharing ways to age in great health.

The changes in our metabolism and body systems that we associate with aging  are variable, and manifest at different times in different individuals. Presbyopia, the difficulty in close up focussing that requires us to get reading glasses, may become problematic in the early forties for some, while others may not experience it until much later in life. Other aging associated changes like wrinkles from  loss of elasticity in our skin, thinning, baldness or greying of our hair, or increasing middle-age spread, also become evident in individuals at  different ages. As women, we become accustomed from puberty, to cyclical fluctuations in our physiology associated with  hormonal changes. These effects are magnified as we transition through menopause and peri-menopause too is variable in timing and duration. Today I speak with award-winning Clinician-Scientist, and 40+ year University of British Columbia Endocrinology Professor. Dr. Jerilynn Prior, about the Paradox of Perimenopause. Dr. Prior's research and innovative concepts are changing women's reproduction. She shows that progesterone must be in balance with estradiol for wellbeing and fertility during the premenopausal years,  and for lifelong good health. In an upcoming episode, Part 2 of my conversation with Dr. Prior, we will be discussing healthy aging, the Growing Older Living Younger mission of aging gracefully and living younger, longer. In 2002, Dr. Prior founded the UBC Centre for Menstrual Cycle and Ovulation Research.  She is an internationally recognized thought leader on menstrual cycles, ovulation, perimenopause, menopause, osteoporosis prevention and treatment of night sweats. Her controlled trials show that progesterone decreases menopausal Vasomotor Symptoms of hot flashes and night sweats, and increases bone formation. Learn more about Dr. Prior and the Centre for Menstrual Cycle and Ovulation Research here www.cemcor.ubc.ca Facebook: Centre for Menstrual Cycle and Ovulation Research (https://www.facebook.com/cemcor.research) To discover how to Reset Your Aging Blueprint and create your own roadmap to living younger as you grow older, you can schedule a free Discovery Call with me.  Order your copy of Growing Older Living Younger: The Science of Aging Gracefully and The Art of Retiring Comfortably here and join our private Growing Older Living Younger Community, to meet people, who like you, are discovering and sharing ways to age in great health.

Television and film like to portray people with schizophrenia as young, white men. And yet, in real life, schizophrenia is not as seen on TV — especially for women. Scientists are now seeing how illnesses like schizophrenia can impact men and women differently, which means more research needs to be done around women and serious mental illnesses. Does this affect women getting an accurate diagnosis or accessing care? And what additional stigma or discrimination might a woman experience?We will cover all of these questions and more with this episode's guest, Dr. Araba Chintoh, associate professor in the University of Toronto's psychiatry department and a Clinician Scientist at the Campbell Family Mental Health Research Institute in the Schizophrenia Division at the Centre for Addiction and Mental Health (CAMH). She's a researcher and clinician committed to exploring the knowledge gaps around treatment resistant schizophrenia, and assessing the differences in the diagnosis, prognosis, adherence, and treatment of psychosis and serious mental illness for women.Resources:Dr. Araba Chintoh's bioWhy is schizophrenia different in women - Discover MagazineWomen and psychosis - CAMHSee omnystudio.com/listener for privacy information.

To celebrate the end of breast cancer awareness month, Michael and Josh are joined by Dr Belinda Yeo, an experienced oncologist specialising in treating breast cancer. Belinda trained at St Vincent's Hospital in Sydney, Australia, followed by the Royal Marsden Hospital in London. She now works at the Olivia Newton-John Cancer Research Institute as a Clinician Scientist with a specific interest in breast cancer and the prestigious Austin Hospital in Melbourne, Australia.We discussed all things breast oncology with Belinda, including career path, research, patient-centred care and, of course, all the breast cancer treatment pearls for any budding oncologist!This is one episode not to miss!For more episodes, resources and blog posts, visit www.inquisitiveonc.comFind us on Twitter @InquisitiveOnc!If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.comDisclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice. Hosted on Acast. See acast.com/privacy for more information.

There is often a gap between what happens in the laboratory and what happens with patients in clinical practice. Yet both experiences are required to advance patient outcomes. This is why we need more doctors like Robert Starke. Dr. Starke is a clinician scientist at the University of Miami with over 700 operations and just as many academic publications in his young career. Join me as I sit down with Dr. Starke to discuss the secrets to his extraordinary success, the grant writing process, and future pathways for the development of clinician scientists in the field of neurosurgery.You will want to hear this episode if you are interested in...Getting to know Dr. Starke, his clinical practice, and his research [0:36]Dr. Starke's evolution into a productive clinician scientist and the challenges of pursuing both basic and clinical science [4:34]Dr. Starke's current research setup and how he chose his area of focus [9:38]How Dr. Starke innovates, where his funding comes from, and the story of his first major grant [16:59]Choosing a faculty position that allows you to thrive and how to build a balanced life [24:58]Dr. Starke's paper writing process and the publications he's most proud of [29:18]The role mentors have played in Dr. Starke's career and what he would do differently [32:15]The importance of training clinician scientists and future pathways for development [37:05]Dr. Starke's three secrets to an extraordinary neurosurgery career and his advice to struggling clinician scientists [40:12]The magic wand question [44:33]Connect with Dr. Robert StarkeDr. Robert M. StarkeFollow Dr. Starke on LinkedIn Connect With Maxwell Boakyehttps://maxwellboakye.com/podcast Like on FacebookFollow on TwitterFollow on LinkedInDrMaxBoakye (at) Gmail.com

Episode 43 of the Long Covid Podcast is a chat with Dr Mohammad Bashashati, Clinician Scientist & Internist  and Senior GI Fellow at Texas Tech University Health Sciences Center in El Paso, Texas. We chat about GI issues in both acute and Long Covid, and the huge numbers of people who present with these issues, despite it being a topic that isn't talked about enough. We chat about DGBI (disorders of the gut brain interaction), what this means and what might help to treat and manage them.Published studyRome Foundation - more information about COVID-19 and GI symptoms hereTwitter hashtag for DGBI  #PostCovid19DGBI~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~The Long Covid Podcast is self-produced & self funded. If you enjoy what you hear and are able to, please Buy me a coffee or purchase a mug to help cover costs.Share the podcast, website & blog: www.LongCovidPodcast.comFacebook @LongCovidPodcastInstagram & Twitter @LongCovidPodFacebook Support GroupSubscribe to mailing listPlease get in touch with feedback and suggestions or just how you're doing - I'd love to hear from you! You can get in touch via the social media links or at LongCovidPodcast@gmail.comDiscovery MattersA collection of stories and insights on matters of discovery that advance life...Listen on: Apple Podcasts Spotify Support the show

At the beginning of her career, Prof Lam thought that being able to multi-task is one of her strengths. After many accomplishments as a cardiologist and a researcher, she believes that there is more power in focus and being fully present. This week's guest on Parallax is Professor Carolyn Lam, Senior Consultant and Director of Women's Heart Health at the National Heart Centre Singapore, Professor at the Duke-National University of Singapore and co-founder of Us2.ai, an award-wining medtech start-up as well as the host of the Circulation on the Run Podcast. In this refreshing and spiritual episode Carolyn reflects on her journey and the decisions and mentors that shaped her career as a heart failure specialist, trialist and as a public speaker. Ankur and Carolyn dive into the question whether being balanced is what we should be all aiming for. Ankur asks Carolyn about her work as a co-founder of Us2.ai, a start-up dedicated to the automation of the fight against heart disease by applying AI to echocardiography. What makes Prof Carolyn Lam tick? What does spirituality and faith mean to Prof Lam? What are her thoughts on the role of AI in the democratization of medicine? What is her advice to our listeners? Questions and comments can be sent to “podcast@radciffe-group.com” and may be answered by Ankur in the next episode. Guest, @lamcardio hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Read Paediatric Neurologist, Clinician-Scientist, Laureate Professor Ingrid Scheffer, AO's piece in the Lancet Neurology: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00002-3/fulltext Here is the quote Mike read: “It will not be feasible to design a gene therapy for each pathogenic variant of every genetic disease, so clever strategies, such as those mentioned earlier, will need to be developed to enable these life-changing therapies to reach a wide variety of patients. The future of child neurology is bright—indeed, far more promising than at the turn of the 21st century. Many devastating diseases now have real hope of targeted therapies, which can cure not just one but all manifestations of the disease and offer the child and family the promise of a normal life.” SRF article on IPSCs: https://www.syngapresearchfund.org/post/another-srf-contribution-to-syngap1-research-patient-derived-cell-lines-to-test-treatments SRF article on reading your genetic report: https://www.syngapresearchfund.org/post/understanding-your-genetic-report-with-syngap1-a-rare-disease SRF article on VUS: https://www.syngapresearchfund.org/post/does-your-genetic-report-contain-a-variant-of-unknown-significance-vus-in-syngap1 REMEMBER Raise funds at https://syngap.fund/give Subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://syngap.fund/10 if you want a direct link for Apple: https://syngap.fund/10a Episode 44 of #Syngap10 - January 21, 2022 #missense #SYNGAP1 #F78A1 #Syngap #epilepsy #autism #intellectualdisability #id #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology #Genetics --- Send in a voice message: https://podcasters.spotify.com/pod/show/syngap10/message